LFUS, TRMB, RES, XRAY & NXPI Intrinsic Values

Today’s Intrinsic Values

Stock Overview

Rundown

LFUS – LITTELFUSE, INC. (HQ: USA/Industry: Electronics, Instruments & Components)
52 Week Lo/Hi Price: 223.31 / 334.84
Previous Closing Price: 257.07
Margin of Safety Intrinsic Value Price: 165.72

10-Year Financial Summary (Recent/Average)
Revenue: $2.1B/$1.2B, with 2 declining years and 43.8% YoY growth
EPS (USD): 11.38/5.38, with 4 declining years and 115.1% YoY growth
BV (USD): 73.93/45.78, with 1 declining year and 18.4% YoY growth
FCF: $283M/$168M, with 3 declining years and 40.1% YoY growth
Dividend: Increased 166%, with 0 declining years
Share Count: Increased 14%

To value the business at the current market price the company would need more than a 15% per year growth for the next 10-years

TRMB – TRIMBLE INC. (HQ: USA/Industry: Electronics, Instruments & Components)
52 Week Lo/Hi Price: 59.89 / 96.49
Previous Closing Price: 64.08
Margin of Safety Intrinsic Value Price: 26.64

10-Year Financial Summary (Recent/Average)
Revenue: $3.7B/$2.7B, with 2 declining years and 16.3% YoY growth
EPS (USD): 1.94/1.05, with 4 declining years and 25.2% YoY growth
BV (USD): 15.47/10.37, with 1 declining year and 15.5% YoY growth
FCF: $704M/$429M, with 2 declining years and 14.5% YoY growth
Company does not pay a dividend
Share Count: Decreased -1%

To value the business at the current market price the company would need more than a 15% per year growth for the next 10-years

RES – RPC, INC. (HQ: USA/Industry: Energy Equipment & Services)
52 Week Lo/Hi Price: 3.33 / 12.91
Previous Closing Price: 10.11
Margin of Safety Intrinsic Value Price: 2.99

10-Year Financial Summary (Recent/Average)
Revenue: $865M/$1.4B, with 5 declining years and 44.6% YoY growth
EPS (USD): 0.03/0.22, with 6 declining years
BV (USD): 2.93/4.02, with 5 declining years and -1.3% YoY decrease
FCF: $-20M/$83M, with 6 declining years and currant year being negative and -253.8% YoY decrease
Company did not pay a dividend last year
Share Count: Decreased -2%

To value the business at the current market price the company would need more than a 12% per year growth for the next 10-years

XRAY – DENTSPLY SIRONA INC. (HQ: USA/Industry: Health Care Equipment & Supplies)
52 Week Lo/Hi Price: 39.22 / 69.54
Previous Closing Price: 40.59
Margin of Safety Intrinsic Value Price: 15.45

10-Year Financial Summary (Recent/Average)
Revenue: $4.3B/$3.5B, with 4 declining years and 27.2% YoY growth
EPS (USD): 1.91/0.17, with 4 declining years
BV (USD): 23.56/22.71, with 5 declining years and 8.2% YoY growth
FCF: $515M/$424M, with 4 declining years and -6% YoY decrease
Dividend: Increased 95%, with 0 declining years
Share Count: Increased 53%

To value the business at the current market price the company would need more than a 11% per year growth for the next 10-years

NXPI – NXP SEMICONDUCTORS NV (HQ: Netherlands/Industry: Semiconductors & Semiconductor Equipment)
52 Week Lo/Hi Price: 164.75 / 239.91
Previous Closing Price: 177.58
Margin of Safety Intrinsic Value Price: 67.66

10-Year Financial Summary (Recent/Average)
Revenue: $11.1B/$7.8B, with 3 declining years and 28.5% YoY growth
EPS (USD): 6.79/3.07, with 4 declining years and 3672.2% YoY growth
BV (USD): 25.43/20.96, with 6 declining years and -19.7% YoY decrease
FCF: $2.1B/$1.6B, with 3 declining years and 9.4% YoY growth
Dividend: Increased 350%, with 1 declining year
Share Count: Increased 11%

To value the business at the current market price the company would need more than a 12% per year growth for the next 10-years

*Growth Grade is an indicator of a company’s growth potential, refer to the Terminology page for a full description.
**Industry averages based on the stocks that have been valued on the website and not for all stocks in an industry.

Intrinsic values provided are intended as reference only. They should never be used as the sole means of valuing a company and/or making investment decisions. As with any investment, an investor should perform their due diligence before investing. This includes understand the investment risks, reviewing financial reporting documents, and consult an investment professional if necessary.

Copyright (C) 2022 Intrinsic Value Index. All rights reserved.